Arcutis Biotherapeutics, Inc.

Bank of New York Mellon Corp ARQT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

304,428

Value ($000)

8,841

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	8,841	0.0%	304,428	12/31/2025
2025 Q3	11/3/2025	5,855	0.0%	310,620	9/30/2025
2025 Q2	8/5/2025	4,280	0.0%	305,258	6/30/2025
2025 Q1	4/29/2025	4,692	0.0%	300,031	3/31/2025
2024 Q4	2/4/2025	4,249	0.0%	305,007	12/31/2024
2024 Q3	11/12/2024	2,893	0.0%	311,059	9/30/2024
2024 Q2	7/25/2024	3,629	0.0%	390,202	6/30/2024
2024 Q1	4/25/2024	3,073	0.0%	310,124	3/31/2024
2023 Q4	1/29/2024	1,027	0.0%	317,927	12/31/2023
2023 Q3	10/24/2023	1,263	0.0%	237,779	9/30/2023
2023 Q2	8/3/2023	2,007	0.0%	210,609	6/30/2023
2023 Q1	5/9/2023	1,498	0.0%	136,155	3/31/2023
2022 Q4	2/14/2023	1,944	0.0%	131,373	12/31/2022
2022 Q3	11/14/2022	2,382	0.0%	124,609	9/30/2022
2022 Q2	8/15/2022	2,034	0.0%	95,427	6/30/2022
2022 Q1	5/11/2022	1,856	0.0%	96,346	3/31/2022
2021 Q4	2/11/2022	2,023	0.0%	97,523	12/31/2021
2021 Q3	11/18/2021	2,271	0.0%	95,064	9/30/2021
2021 Q2	8/11/2021	2,376	0.0%	87,079	6/30/2021
2021 Q1	5/13/2021	2,514	0.0%	86,901	3/31/2021
2020 Q4	2/9/2021	1,871	0.0%	66,527	12/31/2020
2020 Q3	11/12/2020	1,659	0.0%	56,611	9/30/2020
2020 Q2	8/12/2020	1,066	0.0%	35,255	6/30/2020
2020 Q1	5/6/2020	718	0.0%	24,084	3/31/2020